Immunotherapy Patient Forum for the Treatment of Melanoma, Leukemia, Lymphoma, Lung and Genitourinary Cancers

The SITC 2015 Presentation Archive is supported through a generous contribution from AstraZeneca/MedImmune.

Access slide decks and video via the links in the schedule below.

= PDF of slides is available

= Presentation video is available

Program Schedule

Saturday, November 7, 2015

Please use the password GRACE to access the videos below.
8:00 – 8:10 a.m.	Welcome and Introductions Howard L. Kaufman, MD, FACS – Rutgers Cancer Institute of New Jersey
Session I
8:10 – 8:40 a.m.	What is Immunotherapy & Its Mechanisms of Action   James Gulley, MD, PhD – National Cancer Institute
8:40 – 9:05 a.m.	Current Role of Immunotherapy   Michael Atkins, MD – Georgetown-Lombardi Comprehensive Cancer Center
9:05 – 9:25 a.m.	Managing Immunotherapy Side Effects   Evan J. Lipson, MD – John Hopkins University
9:25 – 9:30 a.m.	The Patient Perspective Terrie Schmith
9:30 – 9:45 a.m.	Moderated Q& A H. Jack West, MD – Swedish Cancer Institute
9:45 – 10:00 a.m.	Break
Session II: Break Out Sessions
10:00 – 11:10 a.m.	Melanoma Mario Sznol, MD – Yale School of Medicine  Leukemia/Lymphoma Madhav Dhodapkar, MD – Yale University Lung   Julie Brahmer, MD – John Hopkins University H. Jack West, MD – Swedish Cancer Institute Genitourinary James Gulley, MD, PhD – National Cancer Institute
Session III
11:35 – 11:55 a.m.	Biomarkers and Patient Selection   Julie Brahmer, MD – John Hopkins University
11:55 – 12:15 p.m.	Novel Immunotherapies and Combinations Mario Sznol, MD – Yale School of Medicine
12:15 – 12:35 p.m.	New Approaches to Immunotherapy   Craig L. Slingluff, MD – University of Virginia
12:35 – 1:00 p.m.	Moderated Q&A H. Jack West, MD – Swedish Cancer Institute